MEDTRN — Meditrina Cyprus Balance Sheet
0.000.00%
- €4.50m
- €4.49m
- €6.47m
- 55
- 96
- 31
- 68
Annual balance sheet for Meditrina Cyprus, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.281 | 0.44 | 0.32 | 0.112 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 4.42 | 4.11 | 3.34 | 3.35 |
Total Inventory | ||||
Total Current Assets | 6.46 | 7.74 | 4.32 | 3.99 |
Net Property, Plant And Equipment | 0.028 | 0.032 | 0.003 | 0.003 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Total Assets | 15.6 | 17.2 | 14.4 | 14.4 |
Accounts Payable | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 6.29 | 8.57 | 6.03 | 5.94 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 9.46 | 11.5 | 7.98 | 7.57 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 6.19 | 5.77 | 6.41 | 6.79 |
Total Liabilities & Shareholders' Equity | 15.6 | 17.2 | 14.4 | 14.4 |
Total Common Shares Outstanding |